Clinical trials

  • METFORMIN HYDROCHLORIDE for Rheumatoid arthritis
  • RESMETIROM for Non-alcoholic steatohepatitis (NASH) cirrhosis
  • Chimeric monoclonal antibody against carcinoembryonic antigen conjugated to fluorochrome BM-104 for Early rectal cancer | High-grade dysplasia
  • Human neuronal progenitor/stem cells for Progressive multiple sclerosis
  • CHIMERIC MONOCLONAL ANTIBODY AGAINST CARCINOEMBRYONIC ANTIGEN CONJUGATED TO FLUOROCHROME BM-104 for Rectal cancer
  • BELZUTIFAN for Advanced renal cell carcinoma (clear cell)
  • Metformin hydrochloride for Glioblastoma (Grade 4)
  • IDP-121 for Small cell lung cancer (relapsed/metastatic)
  • TOCILIZUMAB for Chronic active antibody-mediated rejection (kidney transplant recipients)
  • Metformin hydrochloride for Precocious puberty | Overweight
  • Aminolevulinic acid hydrochloride for Ovarian cancer
  • MEXILETINE HYDROCHLORIDE for Myotonic dystrophy type 1 | Myotonic dystrophy type 2